Bipolar Disorder. Guidelines in the Treatment of. National Center for Mental Health

Size: px
Start display at page:

Download "Bipolar Disorder. Guidelines in the Treatment of. National Center for Mental Health"

Transcription

1 Guidelines in the Treatment of Bipolar Disorder ational Center for Mental Health ueve de Febrero St., Mandaluyong City Telephone o.: Website:

2 ational Center for Mental Health ueve de Febrero St., Mandaluyong City Telephone o.: Website: Organizational Structure OIC, Medical Center Chief II Chief, Medical and Professional Staff (Hospital Service) Chief, Medical and Professional Staff (Community Service) Treatment Protocol Committee Beverly A. Azucena, MD, DPBP, FPPA, MMHoA Beverly A. Azucena, MD, DPBP, FPPA, MMHoA Venus S. Arain, MD, DPBP, FPPA (Life), MHA Bernard B. Argamosa, MD, DSBPP Agnes Joy L. Casiño, MD Joeffrey D. Cruzada, MD, DPBP, FPPA Teresa Rosalie D. Del Valle, MD, DPBP, FPPA, MMHoA Victor C. Vinluan Jr., MD, DPBP, FPPA (Life), MHA l Sign up and open your clinic to the world.

3 Algorithm for the Treatment of Bipolar Affective Disorder Characteristic symptoms of Bipolar Affective Disorder 2 History, mental status exam, neuro and physical exam Indication for hospitalization? Commitment Order from the Court? Admit patient 6 Admission for psychosocial reason? 7 Admit patient 8 Baseline lab exams, psychological exam 9 0 High suicide risk? Admit patient Presently disturbed or agitated? Go to B Figure

4 A Outpatient Manic? With psychosis? Medicines from Table and Table 2 Follow up after 2-4 weeks Medicines from Table 2 Re-assessment of patient; monitor adverse event/side effects Depressed? 0 Mixed Go to #2 8 Intolerable side/adverse effects? Continue with present medication Start with individual therapy Psychosocial rehabilitation 2 9 Assess severity of adverse effects Give biperidine HCl or diphenhydramine Go to #2 3 4 Resolution of side effects? Continue medications Go to C Figure 2 l Sign up and open your clinic to the world.

5 B Rapid neuroleptization Improvement of symptoms? Choose medication from Table (Antipsychotic meds) and Table 2 (Mood stabilizers) Intolerable side/ adverse effects? Go to C 5 6 Admit patient Continue medication for 2-4 weeks 7 Baseline lab exams, psychological exam 8 Go to D Figure 3 0

6 C Choose another medications 2 Intolerable side effects? Go to C 3 Continue medication for 2-4 weeks 4 Go to D Figure 4 D Increase the dose of medication 2 3 Choose another medication 4 5 Combination of different medications Go to E Figure 5 l Sign up and open your clinic to the world.

7 E 2 Combination of present medication with the mood stabilizer 3 4 For admission & other treatment modalities Go to B Figure 6 2

8 CMH Guidelines in the Treatment of Bipolar Disorder I. Definition Bipolar disorder (previously called manic-depressive psychosis) consists of at least one hypomanic, manic, or mixed episode. Mixed episodes represent a simultaneous mixture of depressive and manic or hypomanic manifestations. Although a minority of patients experience only manic episodes, most bipolar disorder (BD) patients experience episodes of both polarity. The classical definition of BD suggests that this disorder is characterized by the presence and alteration of manic and depressive episodes with a return to premorbid level of functioning between the episodes and a favorable outcome in comparison to schizophrenia. However, today this not always the case. There are two types of Bipolar Disorder: Bipolar I disorder and Bipolar II disorder. Bipolar I disorder is defined as having a clinical course of one or more manic episodes and, sometimes, major depressive episodes. A mixed episode is a period of at least week in which both a manic episode and a major depressive episode occur almost daily. A variant of bipolar disorder characterized by episodes of major depression and hypomania rather than mania is known as Bipolar II disorder. A manic episode is a distinct period of an abnormally and persistently elevated, expansive, or irritable mood lasting for at least one week or less if a patient must be hospitalized. A hypomanic episode lasts at least four days and is similar to a manic episode except that it is not sufficiently severe to cause impairment in social or occupational functioning, and no psychotic features are present. II. Epidemiology Bipolar disorder is relatively common with a lifetime prevalence of approximately.3%. BD-I has a lifetime prevalence of 0-2.4%, BD-II has a lifetime prevalence of %. Bipolar disorder has an equal prevalence among men and women. Manic episodes are more common in men, and depressive episodes are more common in women. When manic episodes occur in women, they are more likely than men to present a mixed picture. Typically, BD-I starts before the age of 40. Frequently the correct diagnosis is made after several years because the first episode is psychotic-like or depressive and the diagnosis is only evident after a manic or mixed episode emerges. BD-I is more common in divorced and single persons than among married persons, but this difference may reflect the early onset and the resulting marital discord characteristic of the disorder. A higher than average incidence of BD-I is found among the upper socioeconomic groups. III. Etiology A. Genetic Factors Several family, adoption, and twin studies have documented the heritability of mood disorders. B. Biochemical Factors Studies reported biological abnormalities in patients with mood disorders particularly in the monoamine neurotransmitters--- norepinephrine, dopamine, serotonin, and histamine. C. Psychosocial Factors Life events and environmental stress often precede first episode of mood disorders as it is theorized that stress results in long-lasting changes in the brain's biology. Most psychodynamic theories of mania view manic episodes as a defense against underlying depression. IV. Clinical Features and Symptomatology The onset of mood episodes can be acute or insidious, and emerge from a low-grade, intermittent, and protracted mood substrate which can resemble a dysthymic or cyclothymic state or even personality features. These mood states can also prevail during the inter-episode period and may give rise to low quality of life, interpersonal conflicts and significant global disability. Furthermore, these subthreshold disorders are quite frequent in the families of patients. DSM 5 Criteria Manic Episode A. A distinct period of abnormally and persistently elevated, expansive or irritable mood and abnormally and persistently increased goal directed activity or energy, lasting at least week and present most of the day, nearly every day (or any duration if hospitalization is necessary). B. During the period of mood disturbance and increased energy or activity (three or more) of the following symptoms (four if the mood is only irritable) are present to a significant degree and represent a noticeable change from usual behaviour. Inflated self esteem or grandiosity 2. Decreased need for sleep (e.g., feels rested after only 3 hours of sleep) 3. More talkative than usual or pressure to keep talking 4. Flight of ideas or subjective experience that thoughts are racing 5. Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli), as reported or observed 6. Increase in goal directed activity (either socially, or at work or school or sexually) or psychomotor l Sign up and open your clinic to the world. 3

9 agitation (i.e., purposeless non goal directed activity) 7. Excessive involvement in activities that have a high potential for painful consequences (e.g., engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments). C. The mood disturbance is sufficiently severe to cause marked impairment in social or occupational functioning or to necessitate hospitalization to prevent harm to self or others or there are psychotic features. D. The episode is not attributable to the psychological effects of a substance (e.g., a drug of abuse, a medication, other treatment) or to another medical condition ote: a full manic episode that emerges during antidepressant treatment (e.g., medication, ECT) but persists at a fully syndromal level beyond the physiological effect of that treatment is sufficient evidence for a manic episode and therefore a bipolar I diagnosis. ote: Criteria A-D constitutes a manic episode. At least I lifetime manic episode is required for the diagnosis of bipolar I disorder. Hypomanic Episode A. A distinct period of abnormally and persistently elevated, expansive or irritable mood and abnormally and persistently increased activity or energy, lasting at least 4 consecutive days and present most of the day, nearly every day B. During the period of mood disturbance and increased energy or activity, three or more of the following symptoms (four if the mood is only irritable) have persisted, represent a noticeable change from usual behaviour and have been present to a significant degree:. Inflated self esteem or grandiosity 2. Decreased need for sleep (e.g., feels rested after only 3 hour of sleep) 3. More talkative than usual or pressure to keep talking 4. Flight of ideas or subjective experience that thoughts are racing 5. Distractibility (i.e., attention too easily drawn to unimportant or irrelevant external stimuli), as reported or observed 6. Increase in goal directed activity (either socially, at work or school, or sexually) or psychomotor agitation (i.e., purposeless non goal oriented activity). 7. Excessive involvement in activities that have a high potential for painfull consequences (e.g., engaging in unrestrained buying sprees, sexual indiscretions, or foolish business investments) C. The episode is associated with an unequivocal change in functioning that is uncharacteristic of the individual when not symptomatic D. The disturbance in mood and the change in fuctioning are observable by others E. The episode is not severe enough to cause marked impairment in social or occupational functioning or to necessitate hospitalization. If there are psychotic features, the episode is by definition, manic F. The episode is not attributable to the psychological effects of a substance (e.g., a drug of abuse, a medication, other treatment) ote: A full hypomanic episode that emerges during anti-depressant treatment (e.g., medication, electroconvulsive therapy) but persists at a fully syndromal level beyond the physiological effect of that treatment is sufficient evidence for a hypomanic episode diagnosis. However, caution is indicated so that one or two symptoms (particularly increased irritability, edginess or agitation following anti-depressant use) are not taken as sufficient for diagnosis of a hypomanic episode, nor necessarily indicative of a bipolar diathesis. ote: Criteria A-F constitute a hypomanic episode. Hypomanic episodes are common in bipolar I disorder but are not required for the diagnosis of bipolar I disorder. V. Management A. Assessment Mood disorders should be differentially diagnosed from a number of other morbid conditions, both psychiatric and non-psychiatric. Several mental disorders including alcohol and substance use disorders, normal bereavement, depression in the frame of schizophrenia, anxiety disorders, personality disorders, dementia and a variety of general medical conditions that cause syndromes similar to depression should be differentiated from mood disorders. Also several drugs used for the treatment for a number of diseases might also cause depression. In general the prevailing opinion is that a missed diagnosis of mood disorder in favor of another mental diagnosis may mean that the patients does not receive proper treatment, which has serious consequences. B. Treatment Bipolar patients need a core treatment with the so-called mood stabilizers and depending on the episode and the state of the clinical picture additional agents can be used. Treatment is artificially separated into acute phase treatment and maintenance. During the acute-phase the therapist should decide where the patient should be treated (e.g., outpatient, inpatient, day hospital etc). The decision is based on the assessment of issues like the risk of suicide, the patient's insight, comorbidity, severity of impairment and the psychosocial support available. As a general rule, patients who respond to acute-phase treatment receive a similar treatment during the maintenance phase. During that phase, medication should be kept at the same dosage if possible. The first kind of available treatment for mood disorders was psychotherapy. Some kind of psychosocial, moral or psychotherapeutic intervention was available since antiquity; however only during the 20th century psychotherapy was systematically developed as a formal treatment. 4

10 A variety of psychoterapies are today available and to some extend have a proven efficacy in the treatment of mood disorders. Although there are still psychoanalytical and psychodynamicoriented approaches, today most professionals prefer the more pragmatic, short term and focused approaches of behavioral or cognitive therapy or utilize an electric approach. Table A: Conventional/typical antipsychotics Acute dose Maintenance dose Haloperidol Chlorpromazine Table B: Atypical antipsychotics Acute dose Maintenance dose Risperidone Olanzapine Clozapine Quetiapine Amisulpride Aripiprazole Table 2: Mood stabilizers Acute dose Maintenance dose Lamotrigine* Week & 2: 25 mg PO mg/day in 24 hrly divided doses Week 3 & 4: 50 mg PO 24 hrly Week 5: 00 mg PO 24 hrly or divided doses Lithium carbonate 400 mg - 2 g PO in divided doses for st 5-7 days.2 g PO 6-8 hrly Carbamazepine 400 mg/day in divided mg/day PO doses in divided doses Max dose: 600 mg/day Valproic acid mg/day mg/day (valproate, Max dose: 2.5 g/day Max dose: 3000 sodium valproate) mg/day Valproate 750 mg/day mg/day semisodium Max dose: 60 mg/kg/day (divalproex a) * Recommended for Bipolar Depression only l Sign up and open your clinic to the world. 5

11 Index of Drugs Related to the Guideline This index lists the products of interest and/or their therapeutic classifications related to the guideline. This index is not part of the guideline. For the doctor's convenience, brands available in the PPD references are listed under each of the classes. For drug information, refer to the PPD references (PPD, PPD Pocket Version, PPD Text, PPD Tabs, and ATIPSCHOTICS Atypical Antipsychotics Asenapine Saphris Aripiprazole Abdin Abilify Clozapine Clopax Clopixene Leponex irva Olanzapine Epilanz-0 Olavex 5/ Olavex 0 Olazin Olzadin Zyprexa Zyprexa Zydis Paliperidone Invega Invega Sustenna Quetiapine Quekline Queppin Seroquel Seroquel XR Risperidone Renuvie Residon Respixl Riscare Risdin Risperdal Risperdal Consta Risperdal Quicklet Zysda Benzamides Amisulpride Amiabel Solian Butyrophenones Haloperidol Haldol Haldol Decanoas Serenace Zuredel Phenothiazines Fluphenazine Sydepres Chlorpromazine Zycloran Thioxanthenes Flupentixol Fluanxol Fluanxol Depot Other Antipsychotics Lithium carbonate Litcab Quilonium - R ATIDEPRESSATS Selective Serotonin Reuptake Inhibitors (SSRIs) Fluoxetine Adep Drafzin Motivest Prodinl Sertraline Deperin Exulten Zolodin Zoloft Escitalopram Escinal Escivex 5/ Escivex 0 Jovia Lexapro Mentumir Zescita Dapoxetine Priligy Paroxetine Seroxat orepinephrine- Reuptake Inhibitors Duloxetine Cymbalta Benzodiazepines Midazolam Midazolex Sedacum Clorazepate Tranxene Anticonvulsants Carbamazepine Carbilepp Tegretol Zynaps Divalproex Depakote ER / Depakote Sprinkle Epival Zystal Lamotrigine Lamictal Motrigine Zyglia Valproic acid Depacon Depakene Syrup Valpros 6

Guidelines in the Treatment of Major Depressive Disorder

Guidelines in the Treatment of Major Depressive Disorder Guidelines in the Treatment of Major Depressive Disorder ational Center for Mental Health ueve de Febrero St., Mandaluyong City Telephone o.: 531-9001 Website: http://www.ncmh.gov.ph ational Center for

More information

DSM5: How to Understand It and How to Help

DSM5: How to Understand It and How to Help DSM5: How to Understand It and How to Help Introduction: The DSM5 is a foreign language! Three Questions: I. The first was, What the key assumptions made to determine the organization of the DSM5? A. Mental

More information

Depression. University of Illinois at Chicago College of Nursing

Depression. University of Illinois at Chicago College of Nursing Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

Clinical Guideline for the Management of Bipolar Disorder in Adults

Clinical Guideline for the Management of Bipolar Disorder in Adults Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:

More information

Treatment Options for Bipolar Disorder Contents

Treatment Options for Bipolar Disorder Contents Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8

More information

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:

More information

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression Bipolar Disorder J. H. Atkinson, M.D. Professor of Psychiatry HIV Neurobehavioral Research Programs University of California, San Diego KETHEA, Athens Slides courtesy of John Kelsoe, M.D. Bipolar Disorder

More information

Kelly Godecke, MD Department of Psychiatry University of Utah

Kelly Godecke, MD Department of Psychiatry University of Utah Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

DISEASES AND DISORDERS

DISEASES AND DISORDERS DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related

More information

Affective Disorders.

Affective Disorders. Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Mood Disorders for Care Coordinators

Mood Disorders for Care Coordinators Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders

More information

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016 Disclosures: Bipolare Disorder Initial Evaliaton and Referral Criteria

More information

HealthyPlace s Introductory Guide to Bipolar Disorder. By Natasha Tracy

HealthyPlace s Introductory Guide to Bipolar Disorder. By Natasha Tracy HealthyPlace s Introductory Guide to Bipolar Disorder By Natasha Tracy 1 Index Introduction Chapter One Bipolar Disorder Basics Chapter Two Bipolar Disorder Diagnosis Chapter Three Treatment of Bipolar

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

SCID-I (for DSM-IV-TR) Current Manic (NOV 2011) Mood Episodes A. 18

SCID-I (for DSM-IV-TR) Current Manic (NOV 2011) Mood Episodes A. 18 SCID-I (for DSM-IV-TR) Current Manic (NOV 2011) Mood Episodes A. 18 *CURRENT EPISODE CRITERIA IF THOROUGH OVERVIEW OF PRESENT ILLNESS PROVIDES NO BASIS FOR SUSPECTING A CURRENT, MIXED, OR HYPO EPISODE,

More information

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,

More information

NOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression)

NOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression) NOVEL INDICATIONS: Experiences from a Study in MDD with Mixed Features (Mixed Depression) 11 APRIL 2013 Josephine Cucchiaro, PhD Vice President Clinical Operations & Project Management Sunovion Pharmaceuticals

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula

Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Official Name Bipolar Disorder; also referred to as Manic Depression Definitions (DSM-IV-TR, 2000) Bipolar I Disorder

More information

Your journal: how can it help you?

Your journal: how can it help you? Journal Your journal: how can it help you? By monitoring your mood along with other symptoms like sleep, you and your treatment team will be better able to follow the evolution of your symptoms and therefore

More information

DSM-5 Criteria: Bipolar Disorders

DSM-5 Criteria: Bipolar Disorders DSM-5 Criteria: Bipolar Disorders Box 1. Bipolar I Disorder: For a diagnosis of bipolar I disorder, it is necessary to meet the following criteria for a manic episode. The manic episode may have been preceded

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

SCID-I (for DSM-IV-TR) Current MDE (JAN 2007) Mood Episodes A. 5

SCID-I (for DSM-IV-TR) Current MDE (JAN 2007) Mood Episodes A. 5 SCID-I (for DSM-IV-TR) Current MDE (JAN 2007) Mood Episodes A. 5 Did this begin soon after someone close to you died? E. Not better accounted for by bereavement, i.e., after the loss of a loved one, the

More information

Steps for Initiating Electroconvulsive Therapy Treatment

Steps for Initiating Electroconvulsive Therapy Treatment Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral

More information

Bipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry

Bipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Bipolar Disorder Demystified Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Underdiagnoses of Depression In Primary Care 2005 Study of 650 primary care patients on antidepressants

More information

Mood Disorders.

Mood Disorders. Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner

More information

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults

Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Are All Older Adults Depressed? Common Mental Health Disorders in Older Adults Cherie Simpson, PhD, APRN, CNS-BC Myth vs Fact All old people get depressed. Depression in late life is more enduring and

More information

Psychiatric Medication Guide

Psychiatric Medication Guide Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants

More information

April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP

April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP Bipolar disorder (BD), also referred to as manic-depression, presents with dramatic swings in a person s mood and energy level, which affects their

More information

PSYCHIATRY INTAKE FORM

PSYCHIATRY INTAKE FORM Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.

More information

Adult Depression - Clinical Practice Guideline

Adult Depression - Clinical Practice Guideline 1 Adult Depression - Clinical Practice Guideline 05/2018 Diagnosis and Screening Diagnostic criteria o Please refer to Attachment A Screening o The United States Preventative Services Task Force (USPSTF)

More information

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient

More information

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD

More information

Depressive and Bipolar Disorders

Depressive and Bipolar Disorders Depressive and Bipolar Disorders Symptoms Associated with Depressive and Bipolar Disorders Characteristics of mood symptoms Affects a person s well being, school, work, or social functioning Continues

More information

PSYCH 235 Introduction to Abnormal Psychology. Agenda/Overview. Mood Disorders. Chapter 11 Mood/Bipolar and Related disorders & Suicide

PSYCH 235 Introduction to Abnormal Psychology. Agenda/Overview. Mood Disorders. Chapter 11 Mood/Bipolar and Related disorders & Suicide PSYCH 235 Introduction to Abnormal Psychology Chapter 11 Mood/Bipolar and Related disorders & Suicide 1 Agenda/Overview Mood disorders Major depression Persistent Depressive Disorder (Dysthymia) Bipolar

More information

Introduction: Bipolar Disorder started the Journey.

Introduction: Bipolar Disorder started the Journey. Introduction: Bipolar Disorder started the Journey. I. Surge in Diagnosis since 1980. A. Epidemic? B. Changing criteria? C. Root of the problem is in diagnosis and treatment of depression. D. Similar subjective

More information

National Center for Mental Health

National Center for Mental Health National Center for Mental Health 9 de Febrero St., Mandaluyong City Telephone No.: 531-9001 (c/o Dr. Vinluan) Organizational Structure Medical Center Chief II Chief, Medical and Professional Staff (Hospital

More information

Class: Treatment with Medication:

Class: Treatment with Medication: Class: As we have not finished all the material covering disorders, I wanted to give you and overview of some disorders we have not had a chance to discuss. I feel you are well prepared in different types

More information

Mental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP

Mental Health Nursing: Mood Disorders. By Mary B. Knutson, RN, MS, FCP Mental Health Nursing: Mood Disorders By Mary B. Knutson, RN, MS, FCP A Definition of Mood Prolonged emotional state that influences the person s whole personality and life functioning Adaptive Functions

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Single Technology Appraisal NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Single Technology Appraisal Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar disorder in children and adolescents

More information

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer

More information

CASE 5 - Toy & Klamen CASE FILES: Psychiatry

CASE 5 - Toy & Klamen CASE FILES: Psychiatry CASE 5 - Toy & Klamen CASE FILES: Psychiatry A 14-year-old boy is brought to the emergency department after being found in the basement of his home by his parents during the middle of a school day. The

More information

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD

More information

Depressive, Bipolar and Related Disorders

Depressive, Bipolar and Related Disorders Depressive, Bipolar and Related Disorders Robert Kelly, MD Assistant Professor of Psychiatry Weill Cornell Medical College White Plains, New York Lecture available at www.robertkelly.us Financial Conflicts

More information

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA *We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening

More information

Jonathan Haverkampf BIPOLAR DISORDR BIPOLAR DISORDER. Dr. Jonathan Haverkampf, M.D.

Jonathan Haverkampf BIPOLAR DISORDR BIPOLAR DISORDER. Dr. Jonathan Haverkampf, M.D. BIPOLAR DISORDER Dr., M.D. Abstract - Bipolar disorder is a condition affecting an individual s affective states (mood). The different flavors of bipolar disorder have in common that there are alterations

More information

National Center for Mental Health

National Center for Mental Health National Center for Mental Health 9 de Febrero St., Mandaluyong City Telephone No.: 531-91 Organizational Structure Medical Center Chief II Chief, Medical and Professional Staff (Hospital Service) Chief,

More information

Mood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland

Mood Disorders Workshop Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland Mood Disorders Workshop 2010 Dr Andrew Howie / Dr Tony Fernando Psychological Medicine Faculty of Medical and Health Sciences University of Auckland Goals To learn about the clinical presentation of mood

More information

Bipolar Disorder Michael Coudreaut, MD

Bipolar Disorder Michael Coudreaut, MD Bipolar Disorder Michael Coudreaut, MD Consultation liaison psychiatry at Intermountain Medical Center; Adjuctive assistant professor, Departments of psychiaitry, University of Utah; Salt Lake City, Utah

More information

BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD

BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD PROFESSOR DEPARTMENT OF PSYCHIATRY UNIVERSITY

More information

Drugs, Society and Behavior

Drugs, Society and Behavior SOCI 270 Drugs, Society and Behavior Spring 2016 Professor Kurt Reymers, Ph.D. Chapter 8 Medication for Mental Disorders 1. Mental Disorders: a. The Medical Model Model: symptoms diagnosis determination

More information

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability

More information

Riding the Waves: Tools for the Management of Bipolar Disorder

Riding the Waves: Tools for the Management of Bipolar Disorder Riding the Waves: Tools for the Management of Bipolar Disorder Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice Palm Beach Atlantic University Lloyd L. Gregory School

More information

Class Update: Oral Antipsychotics

Class Update: Oral Antipsychotics Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

New Patient Questionnaire

New Patient Questionnaire 4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with

More information

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting

More information

Integration of Two Psychiatric Databases

Integration of Two Psychiatric Databases CS580 Term Project, Final Report Integration of Two Psychiatric Databases Instructor: Professor Clement Yu Wei Zhang, Wei Zhou, Huiyong Xiao Dec. 6, 2002 Table Of Contents I. Introduction...1 1. Project

More information

Review Session 3. Case. Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry

Review Session 3. Case. Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry Review Session 3 Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry Case A 26 y/o F describes difficulty sleeping. She has been feeling steadily overwhelmed and anxious at her

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

Aging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health

Aging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Aging with Bipolar Disorder Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Objectives Define bipolar disorder in the elderly Review comorbidities How does it differ from bipolar in

More information

Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos.

Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos. Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos. Randall Ricardi D.O. Child and Adolescent Psychiatry Phoenix Children s Hospital 6-24-17 10:50am Disclosures

More information

John E. Kraus, M.D., Ph.D.

John E. Kraus, M.D., Ph.D. John E. Kraus, M.D., Ph.D. Chief, Adult Psychiatry, Dorothea Dix Hospital, Raleigh, NC Assistant Professor/Associate Director of Residency Training, Dept. of Psychiatry, UNC Hospitals, Chapel Hill, NC

More information

Antidepressants. Dr Malek Zihlif

Antidepressants. Dr Malek Zihlif Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric

More information

Chapter 6 Mood Disorders and Suicide An Overview of Mood Disorders

Chapter 6 Mood Disorders and Suicide An Overview of Mood Disorders Page 1 Extremes in Normal Mood Chapter 6 Mood Disorders and Suicide An Overview of Mood Disorders Nature of depression Nature of mania and hypomania Types of DSM-IV Depressive Disorders Major depressive

More information

Bipolar Disorders. Disclosure Statement. I have no financial disclosures or conflicts of interest

Bipolar Disorders. Disclosure Statement. I have no financial disclosures or conflicts of interest Bipolar Disorders Ahsan Naseem, MD Diplomate American Board of Psychiatry and Neurology Adult and Geriatric Psychiatry Medical Director Bryan Heartland Psychiatry Bryan Physician Network Partner Cheney

More information

HealthPartners Care Coordination Clinical Care Planning and Resource Guide MENTAL HEALTH

HealthPartners Care Coordination Clinical Care Planning and Resource Guide MENTAL HEALTH The following Evidence Base Guideline was used in developing this clinical care guide: MCG Behavioral Health Guidelines and National Institute of Mental Health (NIMH). Documented Health Conditions: Depression

More information

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious

More information

Bipolar Disorder Update

Bipolar Disorder Update Bipolar Disorder Update William Sanders DO, MS Pine Rest/Michigan State University Psychiatry Residency Director Michigan State University Associate Professor Board Certified Adult and Forensic Psychiatrist

More information

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS

More information

Crisis Intervention Team (CIT) Training

Crisis Intervention Team (CIT) Training Crisis Intervention Team (CIT) Training Student Guide Bipolar Disorder Created by: Nils Rosenbaum Matthew Tinney Lawrence Saavedra Bipolar Disorder What is bipolar disorder? Bipolar disorder is a brain

More information

Bipolar disorder. Paz García-Portilla

Bipolar disorder. Paz García-Portilla Bipolar disorder Paz García-Portilla BD I: Epidemiology Life-time prevalence 1% (0.7 1.8%) 30% with diagnosis and without treatment, or with erroneous diagnosis (major unipolar depression, borderline PD)

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine

More information

Major Depressive Disorder (MDD) in Children under Age 6

Major Depressive Disorder (MDD) in Children under Age 6 in Children under Age 6 Level 0 Comprehensive assessment. Refer to Principles of Practice on page 6. Level 1 Psychotherapeutic intervention (e.g., dyadic therapy) for 6 to 9 months; assessment of parent/guardian

More information

Treatment-resistant depression in primary care

Treatment-resistant depression in primary care Treatment-resistant depression in primary care Interprofessional CME, October 2017 Brian J. Mickey, MD, PhD Associate Professor School of Medicine Department of Psychiatry Disclosures Speakers bureau:

More information

Drugs for Emotional and Mood Disorders Chapter 16

Drugs for Emotional and Mood Disorders Chapter 16 Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,

More information

Contemporary Psychiatric-Mental Health Nursing Third Edition. Introduction. Introduction 9/10/ % of US suffers from Mood Disorders

Contemporary Psychiatric-Mental Health Nursing Third Edition. Introduction. Introduction 9/10/ % of US suffers from Mood Disorders Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 17 Mood Disorders Introduction 12% of US suffers from Mood Disorders MD are a group of psychiatric DO characterized by physical, emotional

More information

Dual Diagnosis: Substance Abuse and Mental Illness

Dual Diagnosis: Substance Abuse and Mental Illness Dual Diagnosis: Substance Abuse and Mental Illness and a review of the major PSYCHIATRIC MEDICINES Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Department of Alcohol & Drug Services

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 05 May 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 05 May 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 05 May 2010 LAMICTAL 2 mg, dispersible / chewable tablet B/30 (CIP: 354 581-7) LAMICTAL 5 mg, dispersible / chewable

More information

COURSES ARTICLE - THERAPYTOOLS.US

COURSES ARTICLE - THERAPYTOOLS.US COURSES ARTICLE - THERAPYTOOLS.US Individual Planning: A Treatment Plan Overview for with Individuals Hypomania and Mania in Bipolar Disorder Control Problems. Individual Planning: A Treatment Plan Overview

More information

Women And Bipolar Spectrum Disorders

Women And Bipolar Spectrum Disorders Women And Bipolar Spectrum Disorders Introduction While bipolar disorder is a mental illness that affects both men and women, clinicians who provide care for female patients with bipolar disorder must

More information

A Primer on Psychotropic Medications. Michael Flaum, MD

A Primer on Psychotropic Medications. Michael Flaum, MD The Iowa Mental Health System and Employment for Individuals with Psychiatric Conditions Iowa Vocational Rehabilitation Services Conference Des Moines, IA, September 18, 2006 A Primer on Psychotropic Medications

More information

Roles of primary care physicians in managing bipolar disorders in adults

Roles of primary care physicians in managing bipolar disorders in adults CPG UPDATE Roles of primary care physicians in managing bipolar disorders in adults Awaluddin A, Jali N, Bahari R, Jamil Z, Haron N on behalf of Development Group Clinical Practice Guidelines Management

More information

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice

More information

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150

More information

Mixing and Matching: Layering Medications as Family Physicians

Mixing and Matching: Layering Medications as Family Physicians Mixing and Matching: Layering Medications as Family Physicians Family Medicine Forum Vancouver, B.C. November 9-12, 2016. Jon Davine, CCFP, FRCP(C) McMaster University Objectives Discuss different examples

More information

Differentiating Unipolar vs Bipolar Depression in Children

Differentiating Unipolar vs Bipolar Depression in Children Differentiating Unipolar vs Bipolar Depression in Children Mai Uchida, M.D. Director, Center for Early Identification and Prevention of Pediatric Depression Massachusetts General Hospital Assistant Professor

More information

DIAN KUANG 馬 萬. Giovanni Maciocia

DIAN KUANG 馬 萬. Giovanni Maciocia DIAN KUANG 癫狂 馬 萬 Giovanni Maciocia 里 BIPOLAR DISORDER (MANIC-DEPRESSION) DIAN Qi and Phlegm stagnating Heart and Spleen deficiency with Phlegm Qi deficiency with Phlegm KUANG Phlegm-Fire harassing upwards

More information

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS

MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS MOOD (AFFECTIVE) DISORDERS and ANXIETY DISORDERS Shelley Klipp AS91 Spring 2010 TIP 42 Pages 226-231 and 369-379 DSM IV-TR APA 2000 Co-Occurring Substance Abuse and Mental Disorders by John Smith Types

More information